Cargando…
Recent perspectives of breast cancer prognosis and predictive factors
Breast cancer is the most common type of cancer affecting women worldwide. Although there have been great improvements in treating the disease and at present between 80 and 90% of the women survive ≥5-years after their primary diagnosis. However, due to the high incidence of the disease >450,000...
Autores principales: | Cao, Su-Sheng, Lu, Cun-Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104147/ https://www.ncbi.nlm.nih.gov/pubmed/27900052 http://dx.doi.org/10.3892/ol.2016.5149 |
Ejemplares similares
-
Recent advances of transcriptomics and proteomics in triple‐negative breast cancer prognosis assessment
por: Li, Yuan, et al.
Publicado: (2022) -
Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis
por: Lee, Yujin, et al.
Publicado: (2023) -
Actionable pharmacogenetic markers for prediction and prognosis in breast cancer
por: Sacco, Keith, et al.
Publicado: (2015) -
Recent perspectives of pediatric mitochondrial diseases
por: Cao, Junhua, et al.
Publicado: (2018) -
Biomarkers of the Metabolic Syndrome and Breast Cancer Prognosis
por: Zhu, Qiu-Li, et al.
Publicado: (2010)